CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 243,735 shares at an average $53.82 ($13,116,671)
- 4 Planned sale Chief Research Officer sold 209,048 shares at an average $62.83 ($13,135,397)
- 4 Planned sale EVP, CHIEF COMMERCIAL OFFICER sold 283,189 shares at an average $63.06 ($17,857,830)
- 4 Planned sale EVP, Head of R&D & CMO sold 44,674 shares at an average $62.34 ($2,785,021)
- 4 Planned sale Chief Legal Officer and GC sold 37,500 shares at an average $62.34 ($2,337,695)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 400,000 shares at an average $63.48 ($25,390,729)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 50,508 shares at an average $62.34 ($3,148,544)
- 4 Planned sale SVP, CHIEF ACCOUNTING OFFICER sold 5,375 shares at an average $62.33 ($335,005)
- 4 Planned sale Director sold 20,000 shares at an average $67.31 ($1,346,106)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 642 shares at $66.37 ($42,610)
- 4 Planned sale Director sold 10,000 shares at an average $63.28 ($632,846)
- 4 Gift CHIEF MEDICAL OFFICER gave 468 shares (gift)
- 4 Planned sale Director sold 10,000 shares at $50.07 ($500,747)
- 4 Planned sale Director sold 4,500 shares at $50.00 ($225,000)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
Page 1 of 28 · 552 filings